Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007
Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019
Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004
The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007
A role of fungal extracts on allergic airway inflammation in the ovalbumin-induced asthma model Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001
Mechanisms of bronchial hyperresponsiveness in asthma Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment Year: 2009
Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice Source: Eur Respir J 2008; 32: 970-978 Year: 2008
Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model Source: Eur Respir J 2004; 24: Suppl. 48, 351s Year: 2004
Airway remedeling in a mouse model of chronic asthma: relation between the degree of airway remodeling and airway hyperresponsiveness Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004
A fully dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a murine model of asthma Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010
The PAR2 -activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology Year: 2004
Effects of active and passive smoking on allergic airway inflammation and airway hyperresponsiveness in mice Source: Eur Respir J 2002; 20: Suppl. 38, 310s Year: 2002
Deficiency of tenascin C attenuates airway hyperresponsiveness in an experimental model of bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 585s Year: 2005
Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008
The role of CCR5 in allergen-induced airway hyperresponsiveness and airway inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009
Dissociation of the effects of a steroid on inflammation compared to airway hyperresponsiveness (AHR) in a model of asthma in conscious mice Source: Eur Respir J 2001; 18: Suppl. 33, 30s Year: 2001
HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008